These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31212368)

  • 1. Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancer.
    Porter LH; Lawrence MG; Wang H; Clark AK; Bakshi A; Obinata D; Goode D; Papargiris M; Mural ; Clouston D; Ryan A; Norden S; Corey E; Nelson PS; Isaacs JT; Grummet J; Kourambas J; Sandhu S; Murphy DG; Pook D; Frydenberg M; Taylor RA; Risbridger GP
    Prostate; 2019 Aug; 79(11):1326-1337. PubMed ID: 31212368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
    Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
    Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer.
    Lawrence MG; Pook DW; Wang H; Porter LH; Frydenberg M; Kourambas J; Appu S; Poole C; Beardsley EK; Ryan A; Norden S; Papargiris MM; Risbridger GP; Taylor RA
    Prostate; 2015 Sep; 75(13):1475-83. PubMed ID: 26177841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods.
    Alkema NG; Tomar T; Duiker EW; Jan Meersma G; Klip H; van der Zee AG; Wisman GB; de Jong S
    Sci Rep; 2015 Oct; 5():14495. PubMed ID: 26440065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of patient-derived xenografts in prostate cancer research.
    Lawrence MG; Taylor RA; Cuffe GB; Ang LS; Clark AK; Goode DL; Porter LH; Le Magnen C; Navone NM; Schalken JA; Wang Y; van Weerden WM; Corey E; Isaacs JT; Nelson PS; Risbridger GP
    Nat Rev Urol; 2023 Jun; 20(6):371-384. PubMed ID: 36650259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintaining viability and characteristics of cholangiocarcinoma tissue by vitrification-based cryopreservation.
    Zeng M; Yang QR; Fu GB; Zhang Y; Zhou X; Huang WJ; Zhang HD; Li WJ; Wang ZY; Yan HX; Zhai B
    Cryobiology; 2017 Oct; 78():41-46. PubMed ID: 28716599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An original patient-derived xenograft of prostate cancer with cyst formation.
    Yoshikawa T; Kobori G; Goto T; Akamatsu S; Terada N; Kobayashi T; Tanaka Y; Jung G; Kamba T; Ogawa O; Inoue T
    Prostate; 2016 Aug; 76(11):994-1003. PubMed ID: 27098584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Derived Xenograft Models for Translational Prostate Cancer Research and Drug Development.
    Philp LK
    Methods Mol Biol; 2024; 2806():153-185. PubMed ID: 38676802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.
    Risbridger GP; Clark AK; Porter LH; Toivanen R; Bakshi A; Lister NL; Pook D; Pezaro CJ; Sandhu S; Keerthikumar S; Quezada Urban R; Papargiris M; Kraska J; Madsen HB; Wang H; Richards MG; Niranjan B; O'Dea S; Teng L; Wheelahan W; Li Z; Choo N; Ouyang JF; Thorne H; Devereux L; Hicks RJ; Sengupta S; Harewood L; Iddawala M; Azad AA; Goad J; Grummet J; Kourambas J; Kwan EM; Moon D; Murphy DG; Pedersen J; Clouston D; Norden S; Ryan A; Furic L; Goode DL; Frydenberg M; Lawrence MG; Taylor RA
    Nat Commun; 2021 Aug; 12(1):5049. PubMed ID: 34413304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing prostate cancer patient derived xenografts: lessons learned from older studies.
    Russell PJ; Russell P; Rudduck C; Tse BW; Williams ED; Raghavan D
    Prostate; 2015 May; 75(6):628-36. PubMed ID: 25560784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a cryopreservation protocol for type A spermatogonia.
    Izadyar F; Matthijs-Rijsenbilt JJ; den Ouden K; Creemers LB; Woelders H; de Rooij DG
    J Androl; 2002; 23(4):537-45. PubMed ID: 12065461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease an--d Serve as Models for Evaluating Cancer Therapeutics.
    Nguyen HM; Vessella RL; Morrissey C; Brown LG; Coleman IM; Higano CS; Mostaghel EA; Zhang X; True LD; Lam HM; Roudier M; Lange PH; Nelson PS; Corey E
    Prostate; 2017 May; 77(6):654-671. PubMed ID: 28156002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of Androgen Receptor Targeting shRNA Inhibits Tumor Growth in Patient-Derived Prostate Cancer Xenografts.
    Thomas PB; Alinezhad S; Joshi A; Sweeney K; Tse BWC; Tevz G; McPherson S; Nelson CC; Williams ED; Vela I
    Curr Oncol; 2023 Oct; 30(11):9437-9447. PubMed ID: 37999103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Prostate Cancer Patient-Derived Xenografts to Investigate Mechanisms of Novel Treatments and Treatment Resistance.
    Lam HM; Nguyen HM; Corey E
    Methods Mol Biol; 2018; 1786():1-27. PubMed ID: 29786784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancer.
    Valta MP; Zhao H; Saar M; Tuomela J; Nolley R; Linxweiler J; Sandholm J; Lehtimäki J; Härkönen P; Coleman I; Nelson PS; Corey E; Peehl DM
    Clin Exp Metastasis; 2016 Apr; 33(4):325-37. PubMed ID: 26873136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
    Paez-Ribes M; Man S; Xu P; Kerbel RS
    PLoS One; 2016; 11(6):e0158034. PubMed ID: 27355476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structure.
    Colombo PE; du Manoir S; Orsett B; Bras-Gonçalves R; Lambros MB; MacKay A; Nguyen TT; Boissière F; Pourquier D; Bibeau F; Reis-Filho JS; Theillet C
    Oncotarget; 2015 Sep; 6(29):28327-40. PubMed ID: 26334103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of immediate cryopreservation on the establishment of patient derived xenografts from head and neck cancer patients.
    Abel L; Durmaz A; Hu R; Longhurst C; Baschnagel AM; Wheeler D; Scott JG; Kimple RJ
    J Transl Med; 2021 Apr; 19(1):180. PubMed ID: 33910584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xenografts of primary human prostatic carcinoma.
    Pretlow TG; Wolman SR; Micale MA; Pelley RJ; Kursh ED; Resnick MI; Bodner DR; Jacobberger JW; Delmoro CM; Giaconia JM
    J Natl Cancer Inst; 1993 Mar; 85(5):394-8. PubMed ID: 8433392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Freezing solution containing dimethylsulfoxide and fetal calf serum maintains survival and ultrastructure of goat preantral follicles after cryopreservation and in vitro culture of ovarian tissue.
    Castro SV; de Carvalho AA; da Silva CM; Faustino LR; Campello CC; Lucci CM; Báo SN; de Figueiredo JR; Rodrigues AP
    Cell Tissue Res; 2011 Nov; 346(2):283-92. PubMed ID: 22006251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.